Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
SPECIFIC PHARMA A/S
A/S
Active
CVR 33161395
Borgmester Christiansens Gade 40, 2450
København SV
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2010 · 15 years old
42 employees
Overvåg
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
SPECIFIC PHARMA A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
63M
126M
189M
252M
140M
2021
123M
2022
178M
2023
211M
2024
219M
2025
EBITDA
DKK millions
46M
35M
23M
12M
0M
17M
2021
10M
-41%
2022
17M
+70%
2023
29M
+71%
2024
37M
+28%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Revenue
139.630
123.270
177.609
210.987
219.329
Staff expenses
-15.042
-15.900
-17.328
-19.602
-20.739
EBITDA
17.499
10.482
17.411
28.945
36.536
Depreciation & amort.
-861
-868
-739
-166
-133
EBIT
16.638
9.614
16.672
28.779
36.403
Net financials
2.338
354
-4.005
3.998
1.091
Profit before tax
18.976
9.968
12.667
32.777
37.494
Tax
4.177
2.199
2.791
7.217
8.255
Net profit
14.799
7.769
9.876
25.560
29.239
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
107.235
103.079
104.981
126.169
134.475
Equity
88.820
85.488
89.564
106.245
111.203
Long-term debt
3.220
1.742
98
198
127
Short-term debt
15.167
15.845
15.311
19.709
23.108
Total debt
18.387
17.587
15.409
19.907
23.235
Financial ratios
5-year trend
EBITDA-margin
16.7%
This company
15.8%
Market median
+6% vs market
2021
2025
Soliditetsgrad
82.7%
This company
38.2%
Market median
+116% vs market
2021
2025
Egenkapitalforrentning
26.3%
This company
18.4%
Market median
+43% vs market
2021
2025
Nettoresultatgrad
13.3%
This company
8.1%
Market median
+64% vs market
2021
2025
Aktivomsætning
1.63×
This company
1.12×
Market median
+46% vs market
2021
2025
Gæld/egenkapital
0.21×
This company
0.62×
Market median
+66% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-02-01 – 2025-01-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-02-01 – 2024-01-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-02-01 – 2023-01-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-02-01 – 2022-01-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2020-02-01 – 2021-01-31
View
PDF
More on SPECIFIC PHARMA A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
